首页 | 本学科首页   官方微博 | 高级检索  
     

冠心病患者脂蛋白(a)水平与肾脏早期损害
引用本文:张南征 甘平. 冠心病患者脂蛋白(a)水平与肾脏早期损害[J]. 贵州医药, 1999, 23(6): 410-411
作者姓名:张南征 甘平
作者单位:[1]贵州省军区田坝干休所 [2]贵阳医学院肾内科
摘    要:为探讨冠心病(CHD)患者脂蛋白(a)〖Lp(a)〗水平与肾脏早期损害的关系,应用ELISA法及化学显色终点法分别检测36例CHD患者血清Lp(a)水平和尿氨基葡萄糖苷酶(NAG)活力。结果,CHD组血Lp(a)及尿NAC均明显 正常对照组,且Lp(a)值与民水NAC活力呈正相关(r=0.42,P〈0.01)。提示,CHD患者Lp(a)水平与肾脏早期损害可能有关。

关 键 词:冠心病 脂蛋白(a) 尿酶 肾脏损害

The Relationship between Serun LP(a) and Early Damage of Kidneys in the Patients with Coronary Heart Disease
Zhang Lanzheng,et al.. The Relationship between Serun LP(a) and Early Damage of Kidneys in the Patients with Coronary Heart Disease[J]. Guizhou Medical Journal, 1999, 23(6): 410-411
Authors:Zhang Lanzheng  et al.
Abstract:The serum level of lipoprotein(2)and the urinary level of N-acetyl-Glucosaminidase(NAG)were determined in 36 patients with coronary heart disease and 30 normal controls,The results showed that the serum Lp(a)and urinary NAG were remarkably increased in these patients in comparison with the controls(P<0.001,P<0.01).The serum Lp(a)and urinary NAG was positive correlated (R=0.42,P<0.01).It is suggested that LP(a)level is risk factor in early damage of kidneys in the patients with coronary heart disease.
Keywords:Coronary heart disease   Lipoprotein(a)  N-Acety-Glucosaminidase
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号